Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Centro Hospitalar Universitário do Algarve - Faro

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Centro Hospitalar Universitário do Algarve (CHUA) - Faro is the largest public university hospital center in Portugal's southernmost region. Operating as a primary hub for the National Health System (SNS), the facility integrates clinical care with medical research and training through its partnership with the University of Algarve and the Algarve Biomedical Center (ABC). The hospital features highly specialized medical services, including a comprehensive Stroke Center equipped for thrombectomies, a recently expanded Intensive Care Unit (ICU), and a dedicated rectal cancer reference center.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Government hospital

Business Subcategory

Source: Google. Government hospital
Source: Trial-derived.
6Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
3Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
11Unique Conditions
Source: Trial-derived.
7Unique Sponsors

Conditions

Source: Trial-derived. Lupus Erythematosus, Systemic (2)Source: Trial-derived. Acute Non-cardioembolic Ischemic Stroke (1)Source: Trial-derived. Atherosclerotic Cardiovascular Disease (1)Source: Trial-derived. Cardiovascular Diseases (1)Source: Trial-derived. COVID-19 (1)Source: Trial-derived. Dyslipidemia (1)Source: Trial-derived. Emerging Infectious Disease (1)Source: Trial-derived. High-risk Transient Ischemic Attack (1)

Sponsors

Source: Trial-derived. Viatris Innovation GmbH (2)Source: Trial-derived. Bayer (1)Source: Trial-derived. Boehringer Ingelheim (1)Source: Trial-derived. Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (1)Source: Trial-derived. Epidemiological and Clinical Research Information Network (1)Source: Trial-derived. Institut National de la Santé Et de la Recherche Médicale, France (1)Source: Trial-derived. Oslo University Hospital (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom